MedTrace Logo

Healthcare Transition of Adolescents With Chronic Health Conditions

NCT04631965 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 503

Last updated 2021-12-21

No results posted yet for this study

Summary

At least 12% of children have a chronic disease that requires regular medical follow-up after patients reach legal maturity. This international study aims to provide prospective evidence for improving health and wellbeing outcomes in this population.

The primary hypothesis is that transition readiness will be more strongly associated with adherence to follow-up, fewer emergency visits and continued education than disease severity or chronological age.

The secondary hypothesis is that positive experiences of care will be associated with lower levels of anxiety. Positive care experiences and low anxiety will predict better health-related quality of life during the transition period.

A cohort of 504 young patients will be followed for three years. Patients have been recruited from pediatric hospitals 0-12 months prior to the transfer of care and follow-up will be completed after the patients have been followed for two years in adult healthcare.

Conditions

Interventions

BEHAVIORAL

Transition support service

The hospital-wide transition support service provides systematic care coordination for young patients prior to the transfer of care

Sponsors & Collaborators

  • Pediatric Research Center

    collaborator UNKNOWN

  • Foundation for Medical Research

    collaborator OTHER

  • Foundation for Paediatric Research, Finland

    collaborator OTHER

  • The Paulo Foundation

    collaborator OTHER

  • Royal Children's Hospital

    collaborator OTHER

  • Murdoch Childrens Research Institute

    collaborator OTHER

  • University of Melbourne

    collaborator OTHER

  • University of Helsinki

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2021-12-31
Completion
2023-12-31

Countries

  • Australia
  • Finland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04631965 on ClinicalTrials.gov